Evidence map›Paper›PMID 40447840›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

The clinical value of FAPI PET/CT in delineating target volumes for nasopharyngeal carcinoma.

Wansu Xu, Yihe Zou, Yang Zhang, Qiyuan Lv, Xia Deng, Kejie Li, Xuemei Zhang, Junhui Wang, Wenliang Yu, Raoying Xie and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Prospective comparison of [European journal of nuclear medicine and molecular imaging · 2026
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wansu Xu *Department of Radiation Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, RD. Minjiang, Dist. Kecheng, Quzhou, Zhejiang, China.
Yihe Zou *The First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yang Zhang *The First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Qiyuan LvDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xia DengDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Kejie LiDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xuemei ZhangDepartment of Radiation Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, RD. Minjiang, Dist. Kecheng, Quzhou, Zhejiang, China.
Junhui WangDepartment of Radiation Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, RD. Minjiang, Dist. Kecheng, Quzhou, Zhejiang, China.
Wenliang YuDepartment of Radiation Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, RD. Minjiang, Dist. Kecheng, Quzhou, Zhejiang, China.
Raoying XieDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Meng SuDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Huijuan HeDepartment of Radiation Oncology, Quzhou People's Hospital, The Quzhou Affiliated Hospital of Wenzhou Medical University, RD. Minjiang, Dist. Kecheng, Quzhou, Zhejiang, China. 13186707211@163.com.
Changlin ZouDepartment of Radiotherapy and Chemotherapy, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. zcl19670115@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the efficacy of

methodsAutomatic delineation of the primary tumor target volume was conducted for 21 newly diagnosed NPC patients using

resultsThere were variations in the primary tumor target volume across the different imaging methods. There were no significant differences observed between GTV-FAPI 20%, GTV-FAPI 25%, and GTV-FAPI 30% compared to GTV-MRI. Among them, GTV-FAPI 20% showed the closest similarity to GTV-MRI.

conclusions

Indexed as

Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedTumor Burden18F-AIF-NOTA-FAPI-04Nasopharyngeal carcinomaPET/CTRadiation therapy

Identifiers

PMID40447840
PMCPMC12660409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.